S. Raher

发表

Mannose 6-Phosphate/Insulin-like Growth Factor II Receptor Mediates Internalization and Degradation of Leukemia Inhibitory Factor but Not Signal Transduction*

B. Hoflack, P. Vusio, L. Duplomb, 1999, The Journal of Biological Chemistry.

Macroporous calcium phosphate ceramic for long bone surgery in humans and dogs. Clinical and histological study.

G. Daculsi, N. Passuti, R. Legeros, 1990, Journal of biomedical materials research.

The Mannose 6-Phosphate/Insulin-like Growth Factor II Receptor Is a Nanomolar Affinity Receptor for Glycosylated Human Leukemia Inhibitory Factor*

J. Moreau, B. Hoflack, P. Vusio, 1998, The Journal of Biological Chemistry.

An ELISA for the measurement of human leukemia inhibitory factor in biological fluids and culture supernatants.

M. Jadoul, D. de Groote, P. Franchimont, 1994, Journal of immunological methods.

Modulation of LIF expression in human melanoma cells by oncostatin M.

D. de Groote, D. Heymann, F. Blanchard, 1995, Immunology letters.

Upmodulation of αvβ1 integrin expression on human tumor cells by human interleukin for DA cells/leukemia inhibitory factor and oncostatin M: Correlation with increased cell adhesion on fibronectin

D. Heymann, J. Harb, S. Raher, 1995, Journal of cellular biochemistry.

Interleukin-4 (IL-4), but not IL-10, regulates the synthesis of IL-6, IL-8 and leukemia inhibitory factor by human bone marrow stromal cells.

V. Praloran, Y. Denizot, S. Raher, 1999, Biochimica et biophysica acta.

Natural Splicing of Exon 2 of Human Interleukin-15 Receptor α-Chain mRNA Results in a Shortened Form with a Distinct Pattern of Expression*

F. Magrangeas, S. Minvielle, P. Lehours, 1999, The Journal of Biological Chemistry.

Generation of monoclonal antibodies against HILDA/LIF and their use in the quantitative assay of the cytokine.

M. Jadoul, D. de Groote, J. Soulillou, 1993, Cytokine.

Epitope-function relationships of human leukemia inhibitory factor receptors using a novel set of anti-gp190 mAB.

M. Hallet, J. Taupin, F. Blanchard, 1997, International immunology.

Increased levels of leukaemia inhibitory factor (LIF) in urine and tissue culture supernatant from human primary bone tumours.

G. Daculsi, D. de Groote, D. Heymann, 1998, Cytokine.

Abnormal production of interleukin (IL)-11 and IL-8 in polycythaemia vera.

E. Lippert, S. Hermouet, Y. Jacques, 2002, Cytokine.

Effect of cytokines and lipid mediators on the synthesis of interleukin 1 beta by human bone marrow stromal cells.

V. Praloran, Y. Denizot, S. Raher, 2000, Cytokine.

Leukaemia inhibitory factor (LIF) production in pleural effusions: comparison with production of IL-4, IL-8, IL-10 and macrophage-colony stimulating factor (M-CSF).

V. Praloran, E. L’her, D. de Groote, 1996, Cytokine.

High and Low Affinity Receptors for Human Interleukin for DA Cells / Leukemia Inhibitory Factor on Human Cells

I. Anegon, D. Heymann, J. Soulillou, 2001 .

High and low affinity receptors for human interleukin for DA cells/leukemia inhibitory factor on human cells. Molecular characterization and cellular distribution.

I. Anegon, D. Heymann, J. Soulillou, 1992, The Journal of biological chemistry.

Lipid mediators modulate the synthesis of interleukin 8 by human bone marrow stromal cells.

V. Praloran, Y. Denizot, S. Raher, 1999, Cytokine.

Soluble mannose 6-phosphate/insulin-like growth factor II (IGF-II) receptor inhibits interleukin-6-type cytokine-dependent proliferation by neutralization of IGF-II.

Yannick Jacques, Benjamin Chaigne-Delalande, Frederic Blanchard, 2003, Endocrinology.

Binding of Leukemia Inhibitory Factor (LIF) to Mutants of Its Low Affinity Receptor, gp190, Reveals a LIF Binding Site Outside and Interactions between the Two Cytokine Binding Domains*

S. Daburon, J. Moreau, J. Taupin, 1999, The Journal of Biological Chemistry.

Subunit structure of the high and low affinity human interleukin-15 receptors.

S. Dubois, Y. Jacques, S. Raher, 2000, European cytokine network.

Leukemia inhibitory factor (LIF) and oncastsin M (OSM) high affinity binding require additional receptor subunits besides GP130 and GP190.

M. Hallet, D. Heymann, F. Blanchard, 1996, Cytokine.

[Modulation of integrin alpha-v-beta-1 expression on human tumor cells by leukemia inhibitory factor (LIF) and oncostatin M (OSM)].

D. Heymann, J. Harb, F. Blanchard, 1996, Bulletin du cancer.

An in-vitro study of enamel protein degradation in developing bovine enamel.

S. Raher, J. Ménanteau, D. Mitre, 1986, Archives of Oral Biology.